211 related articles for article (PubMed ID: 33106625)
41. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas.
Lu D; Patel KA; Duvic M; Jones D
J Cutan Pathol; 2002 Sep; 29(8):465-72. PubMed ID: 12207740
[TBL] [Abstract][Full Text] [Related]
42. Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome.
Weiss LM; Wood GS; Hu E; Abel EA; Hoppe RT; Sklar J
J Invest Dermatol; 1989 Apr; 92(4):601-4. PubMed ID: 2784818
[TBL] [Abstract][Full Text] [Related]
43. Sézary Syndrome in a 17-Year-Old Boy: Clinicopathologic Features and Genomic Profile.
Alberti-Violetti S; Vezzoli P; Corti L; Fanoni D; Merlo V; Venegoni L; Reseghetti A; Berti E
Pediatr Dermatol; 2016 Sep; 33(5):e318-21. PubMed ID: 27397596
[TBL] [Abstract][Full Text] [Related]
44. Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity.
Balfour EM; Glusac EJ; Heald P; Talley LL; Smoller BR
J Cutan Pathol; 2003 Aug; 30(7):437-42. PubMed ID: 12859741
[TBL] [Abstract][Full Text] [Related]
45. Sézary syndrome without erythroderma: A case report and review of published work.
Kamijo H; Miyagaki T; Norimatsu Y; Shishido-Takahashi N; Kuzumi A; Asano Y; Sato S
J Dermatol; 2019 Jan; 46(1):61-64. PubMed ID: 30379353
[TBL] [Abstract][Full Text] [Related]
46. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
48. Sézary syndrome and related variants of classic cutaneous T-cell lymphoma. A descriptive and prognostic clinicopathologic study of 29 cases.
Marti RM; Pujol RM; Servitje O; Palou J; Romagosa V; Bordes R; González-Castro J; Miralles J; Gallardo F; Curcó N; Gómez X; Domingo A; Estrach T
Leuk Lymphoma; 2003 Jan; 44(1):59-69. PubMed ID: 12691143
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of cloning rearrangement of T-cell receptor gamma gene in primary cutaneous lymphoma].
Pawlaczyk M; Kistowska M; Poreba E; Filas V; Breborowicz J; Goździcka-Józefiak A
Pol Merkur Lekarski; 2003 Nov; 15(89):420-3. PubMed ID: 14969134
[TBL] [Abstract][Full Text] [Related]
50. TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples.
Ponti R; Fierro MT; Quaglino P; Lisa B; Paola Fd; Michela O; Paolo F; Comessatti A; Novelli M; Bernengo MG
J Invest Dermatol; 2008 Apr; 128(4):1030-8. PubMed ID: 17989737
[TBL] [Abstract][Full Text] [Related]
51. Secondary malignant neoplasms in 71 patients with Sézary syndrome.
Scarisbrick JJ; Child FJ; Evans AV; Fraser-Andrews EA; Spittle M; Russell-Jones R
Arch Dermatol; 1999 Nov; 135(11):1381-5. PubMed ID: 10566838
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.
Bernengo MG; Quaglino P; Novelli M; Cappello N; Doveil GC; Lisa F; De Matteis A; Fierro MT; Appino A
Ann Oncol; 1998 Aug; 9(8):857-63. PubMed ID: 9789608
[TBL] [Abstract][Full Text] [Related]
53. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
Horna P; Moscinski LC; Sokol L; Shao H
Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
[TBL] [Abstract][Full Text] [Related]
54. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
[TBL] [Abstract][Full Text] [Related]
56. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
57. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
[TBL] [Abstract][Full Text] [Related]
58. Transformation of Sézary syndrome into CD30+ anaplastic large T-cell lymphoma after alemtuzumab therapy with evidence of clonal unity.
Nevet MJ; Zuckerman T; Sahar D; Bergman R
Am J Dermatopathol; 2015 Jan; 37(1):73-7. PubMed ID: 25548993
[TBL] [Abstract][Full Text] [Related]
59. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
[TBL] [Abstract][Full Text] [Related]
60. Drug-induced pseudo-Sezary syndrome: a case report and literature review.
Reeder MJ; Wood GS
Am J Dermatopathol; 2015 Jan; 37(1):83-6. PubMed ID: 25033012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
